Alphagan P Solution/ Drops
Product Images NDC 0023-9321

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Alphagan P (NDC 0023-9321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alphagan P 01

Chemical structure of brimonidine tartrate, the active ingredient in ALPHAGAN P. The diagram shows the molecular arrangement including a bromine-substituted quinoxaline moiety and the tartrate component.*

FDA Label Image

Alphagan P 02

FDA Label Image

Alphagan P 03

Packaging label for Alphagan P 0.1% ophthalmic solution (brimonidine tartrate) in a 10 mL bottle. The label shows the Allergan, Inc. brand, active ingredient concentration of 0.1%, and details such as sterility and prescription-only status. The box includes ingredient and storage information along with barcodes.*

FDA Label Image

Alphagan P 04

ALPHAGAN P 0.15% ophthalmic solution (brimonidine tartrate) packaging label. The label states a 10 mL bottle size and includes ingredients, storage instructions, and usage information. Labeler is Allergan, Inc. The label shows active ingredient concentration as 0.15% and displays barcodes on multiple panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.